SCHEMBL6922640

SCHEMBL6922640

FC(F)(F)c1ccccc1Oc1ccc(CC2CCNCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.51
SLC6A2 P23975 9/20 0.48
SLC6A4 P31645 9/20 0.48
SLC6A3 Q01959 6/20 0.48
HTR1A P08908 5/20 0.48
LTA4H P09960 1/20 0.45
PTGS2 P35354 1/20 0.45
HTR2C P28335 2/20 0.43
LPAR1 Q92633 1/20 0.40
LPAR5 Q9H1C0 1/20 0.40
FFAR1 O14842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3895131 0.85 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HTR1ALTA4H
SCHEMBL6926483 0.83 GBA1 (0.55) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6922636 0.82 SLC6A4 (0.50) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6922709 0.80 GBA1 (0.50) GBA1SLC6A2SLC6A4LTA4HHTR2C
SCHEMBL7526770 0.79 GBA1 (0.71) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6923984 0.79 SLC6A2 (0.51) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6927394 0.78 GBA1 (0.53) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6922681 0.78 GBA1 (0.54) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6929247 0.77 GBA1 (0.51) GBA1SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6922705 0.77 SLC6A4 (0.45) GBA1SLC6A2SLC6A4SLC6A3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518284-B2 For inhibiting the serotonin and/or noradrenaline reuptake, and are useful as medicaments in disorders in which an increase of levels of those neurotransmitters is necessary FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS S.A. (ES) 2003-02-11 US claimed
EP-1002794-A1 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-05-24 EP claimed